C3.ai Inc (AI) Stock Price Today
Aura AI Summary
Key Stats
- $1.70BMarket Cap
- 5,528,114Volume
- TechnologySector
- $19.6652W High
- $7.7652W Low
- 136 DaysTypical Hold Time
- $1.05BEnterprise Value
- -Div Yield
- -Trading Activity
Track C3.ai Inc (AI) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, C3.ai Inc has traded between a low of $7.76 and a high of $19.66, highlighting its annual price range. Buy and sell C3.ai Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Most Recent News
Marvell Technology set for strong AI-driven growth with earnings expected to double every two years.
Marvell Technology is positioned as a key supplier for the growing AI datacenter market, with earnings projected to double every two years over the next four years. This growth is driven by strong demand for its data center products and strategic par...

US Treasury yields top 5%, raising debt spiral fears but no fiscal crisis yet.
US Treasury yields have risen above 5%, sparking concerns about a potential debt spiral where rising interest costs force more borrowing. However, experts say a fiscal crisis is not imminent because the US economy's strong growth helps keep debt mana...

Aroa Biosurgery's Symphony significantly improves diabetic foot ulcer healing in US trial.
Aroa Biosurgery reported positive results from a US clinical trial showing its Symphony wound care product improved healing outcomes for diabetic foot ulcers. In a study of 143 patients across 10 US sites, 55% of ulcers treated with Symphony plus sta...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.